Sanofi Pasteur Inc v. Pfizer Inc

Gerald Worth

Amir A. Naini

Siegmund Y. Gutman

Fangli Chen

Peter Cuomo

Andrej Barbic

David M. Hanna

Dimitrios T. Drivas

John Scheibeler

Anita Varma

Brendan Gabin

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Sanofi challenges Pfizer's pneumococcal vaccine patent: GSK & Merck art cited for obviousness against all 45 claims over 22F glycoconjugate parameters.

Merck Sharp & Dohme Corp

Last Docket Entry Date

Total Docket Entries

IPR2018-00187 | Sanofi Pasteur Inc v. Pfizer Inc | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
David C McKone	1000+	76%	85%
Frederick C Laney	700+	80%	83%
Jacqueline T Harlow	200+	56%	83%
Jeffrey N Fredman	100+	74%	85%
Karl D Easthom	1000+	78%	88%
Ryan H Flax	200+	79%	72%
Timothy G Majors	100+	78%	63%
Toni R Scheiner	200+	52%	86%

Name	Ratings
Mintz Levin Cohn Ferris Glovsky & Popeo	L4 A
Peter Cuomo	L5 E
Siegmund Y. Gutman	L2 B
David M. Hanna	-- -- --
Proskauer Rose LLP	L3 B
Amir A. Naini	L2 D
Fangli Chen	L2 D
Gerald Worth	L1 D
Andrej Barbic	-- -- --

Name	Ratings
White & Case LLP	L4 C
John Scheibeler	L3 E
Dimitrios T. Drivas	L1 C
Anita Varma	-- -- --
Brendan Gabin	-- -- --